Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$313K Buy
6,751
+714
+12% +$37.6K ﹤0.01% 1729
2025
Q4
$317K Sell
6,037
-101
-2% -$5.12K ﹤0.01% 1714
2025
Q3
$334K Buy
+6,138
New +$329K ﹤0.01% 1668
2019
Q2
Sell
-614
Closed -$32K 1088
2019
Q1
$32K Buy
+614
New +$38.3K ﹤0.01% 913
2018
Q2
Sell
-1,677
Closed -$111K 1011
2018
Q1
$111K Buy
1,677
+870
+108% +$72.9K 0.01% 863
2017
Q4
$77K Buy
+807
New +$78.9K ﹤0.01% 811

Other funds holding VEON

Atria Investments's VEON Position: Q1 2026 in Review

Atria Investments increased its VEON (VEON) stake by 12% in Q1 2026, buying an estimated $37.6K and bringing the position to 6,751 shares worth $313K. The position accounts for ﹤0.01% of the portfolio, ranked #1729.

Atria Investments first reported a position in VEON in Q4 2017 and has held it in 6 quarters since. The position peaked at $334K in Q3 2025. 101 funds tracked by Wall St. Rank hold VEON as of Q1 2026.

  • Atria Investments held 6,751 shares of VEON worth $313K as of Q1 2026.
  • Atria Investments bought 714 VEON shares in Q1 2026, an estimated $37.6K.
  • VEON made up ﹤0.01% of Atria Investments's portfolio in Q1 2026, its #1729 holding.
  • Atria Investments first reported a position in VEON in Q4 2017 and has held it in 6 quarters since.
  • Atria Investments's VEON position peaked at $334K in Q3 2025.
  • 101 funds tracked by Wall St. Rank held VEON as of Q1 2026.

Based on Atria Investments's 13F filing for Q1 2026, filed 5 May 2026.